IgG receptor FcRn large subunit p51 — Drug Target

All drugs that target IgG receptor FcRn large subunit p51 — marketed and clinical-stage. Includes 2 drug classes acting on this target.

Drug classes

Endoglycosidase [EPC] · Neonatal Fc Receptor Blocker [EPC]

Marketed (2)

• Vyvgart · Argenx Bv · Endoglycosidase [EPC] · Immunology
  Vyvgart works by binding to the p51 subunit of the FcRn receptor, preventing it from recycling antibodies back into the bloodstream.
• RYSTIGGO · UCB INC · Neonatal Fc Receptor Blocker [EPC] · Other